These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7274622)

  • 1. [Clinico-pathogenetic problems and therapeutic approach in hepatic steatosis].
    Fiaccadori F; Ghinelli F; Magnani G; Pelosi G; Sacchini D; Tedeschi F
    G Clin Med; 1981 May; 62(5):326-38. PubMed ID: 7274622
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of steatosis to cirrhosis.
    Thaler H
    Clin Gastroenterol; 1975 May; 4(2):273-80. PubMed ID: 1126047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of fatty liver].
    Trux F
    Z Arztl Fortbild (Jena); 1976 Jan; 70(2):66-70. PubMed ID: 960747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Zieve's syndrome (hepatic steatosis with hyperlipemia, jaundice and hemolytic anemia)].
    Alcalá-Santaella R
    Rev Clin Esp; 1968 Feb; 108(3):183-8. PubMed ID: 5740490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic alcoholic intoxication and cirrhosis of the liver].
    Mansurov KhKh
    Klin Med (Mosk); 1976 Jul; 54(7):10-5. PubMed ID: 979081
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty liver, cirrhosis, and metabolic effects related to problem drinking.
    Lieber CS
    Psychiatr Res Rep Am Psychiatr Assoc; 1968 Mar; 24():119-31. PubMed ID: 4889328
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesterolone in steatosis and cirrhosis of the liver.
    Figueroa RB
    Acta Hepatogastroenterol (Stuttg); 1973; 20(4):282-90. PubMed ID: 4760412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of anabolic hormones on the liver in chronic alcohol intoxications and protein deficiencies].
    Becker K
    Verh Dtsch Ges Inn Med; 1969; 75():325-7. PubMed ID: 5408063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Zieve's syndrome. Relationship to clinico-pathological forms of alcoholic liver diseases in 4 personal studies].
    Vavros B; Dostalík Z
    Vnitr Lek; 1973 Nov; 19(11):1117-29. PubMed ID: 4754620
    [No Abstract]   [Full Text] [Related]  

  • 10. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis.
    Mendenhall CL
    Am J Dig Dis; 1968 Sep; 13(9):783-91. PubMed ID: 5672729
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Fatty liver-steatonecrosis-cirrhosis.
    Thaler H
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):271-3. PubMed ID: 1199665
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alcoholic fatty liver--its regression by alcohol abstinence].
    Lelbach WK
    Munch Med Wochenschr; 1971 Nov; 113(46):1549-57. PubMed ID: 5171315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current problems in the treatment of hepatic cirrhosis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alcoholism, fatty liver and liver cirrhosis].
    Meyer zu Schwabedissen O
    Med Welt; 1969 Mar; 10():519. PubMed ID: 5772238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of corticosteroids and anabolic steroids in the treatment of patients with liver cirrhosis].
    Markov MI; Piralov GV
    Vrach Delo; 1972 Apr; 4():70-2. PubMed ID: 5048960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Steatosis and hepatitis C].
    Testino G
    Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipemia and alcoholic cirrhosis.
    Rickets HT
    JAMA; 1973 Sep; 225(12):1529. PubMed ID: 4740728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fatty liver. Classification, etiopathogenicity and clinical aspects].
    Kuntz E
    Munch Med Wochenschr; 1971 Nov; 113(46):1540-9. PubMed ID: 5171314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inquiries on the etiology, pathogenesis, therapeutic successes and survival time in a random group of 560 patients with liver cirrhosis].
    Creutzfeldt W; Beck K
    Dtsch Med Wochenschr; 1966 Apr; 91(15):682-9. PubMed ID: 5932096
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of liver cirrhosis].
    Kommerell B
    Dtsch Med Wochenschr; 1971 Mar; 71(10):430-2. PubMed ID: 5545292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.